keech hospice

Live MatureMidHealthy

keech hospice Company Information

Share KEECH HOSPICE

Company Number

02904446

Directors

Peter Cannon

Miriam Heyes

View All

Shareholders

-

Group Structure

View All

Industry

Other human health activities

 

Registered Address

keech hospice care, great bramingham lane, luton, LU3 3NT

keech hospice Estimated Valuation

£9.9m

Pomanda estimates the enterprise value of KEECH HOSPICE at £9.9m based on a Turnover of £15.4m and 0.64x industry multiple (adjusted for size and gross margin).

keech hospice Estimated Valuation

£5.4m

Pomanda estimates the enterprise value of KEECH HOSPICE at £5.4m based on an EBITDA of £1.1m and a 4.89x industry multiple (adjusted for size and gross margin).

keech hospice Estimated Valuation

£47.2m

Pomanda estimates the enterprise value of KEECH HOSPICE at £47.2m based on Net Assets of £21.1m and 2.23x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Keech Hospice Overview

Keech Hospice is a live company located in luton, LU3 3NT with a Companies House number of 02904446. It operates in the other human health activities sector, SIC Code 86900. Founded in March 1994, it's largest shareholder is unknown. Keech Hospice is a mature, mid sized company, Pomanda has estimated its turnover at £15.4m with healthy growth in recent years.

View Sample
View Sample
View Sample

Keech Hospice Health Check

Pomanda's financial health check has awarded Keech Hospice a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

7 Strong

positive_score

2 Regular

positive_score

3 Weak

size

Size

annual sales of £15.4m, make it larger than the average company (£731.1k)

£15.4m - Keech Hospice

£731.1k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 7%, show it is growing at a similar rate (7.2%)

7% - Keech Hospice

7.2% - Industry AVG

production

Production

with a gross margin of 38.4%, this company has a comparable cost of product (38.4%)

38.4% - Keech Hospice

38.4% - Industry AVG

profitability

Profitability

an operating margin of 3.9% make it less profitable than the average company (5.2%)

3.9% - Keech Hospice

5.2% - Industry AVG

employees

Employees

with 266 employees, this is above the industry average (18)

266 - Keech Hospice

18 - Industry AVG

paystructure

Pay Structure

on an average salary of £35.5k, the company has a higher pay structure (£26.5k)

£35.5k - Keech Hospice

£26.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £57.9k, this is more efficient (£45.8k)

£57.9k - Keech Hospice

£45.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 1 days, this is earlier than average (20 days)

1 days - Keech Hospice

20 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 14 days, this is quicker than average (18 days)

14 days - Keech Hospice

18 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 0 days, this is less than average (13 days)

0 days - Keech Hospice

13 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 320 weeks, this is more cash available to meet short term requirements (124 weeks)

320 weeks - Keech Hospice

124 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 4.8%, this is a lower level of debt than the average (22.7%)

4.8% - Keech Hospice

22.7% - Industry AVG

KEECH HOSPICE financials

EXPORTms excel logo

Keech Hospice's latest turnover from March 2024 is £15.4 million and the company has net assets of £21.1 million. According to their latest financial statements, Keech Hospice has 266 employees and maintains cash reserves of £6.5 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover15,402,00013,395,00015,879,00012,629,00010,973,00010,150,00010,657,00010,051,0009,914,00010,198,00010,484,0008,454,0007,755,0007,517,0006,982,000
Other Income Or Grants
Cost Of Sales9,484,7948,346,87110,101,3588,301,3957,012,5466,597,9926,706,9426,133,2236,186,9886,350,8936,506,7245,100,9904,462,4964,226,5393,956,467
Gross Profit5,917,2065,048,1295,777,6424,327,6053,960,4543,552,0083,950,0583,917,7773,727,0123,847,1073,977,2763,353,0103,292,5043,290,4613,025,533
Admin Expenses5,312,6183,912,322-304,7721,862,9953,668,3454,187,3193,555,7593,791,2793,331,6642,558,4662,138,3242,949,8403,273,3272,842,8233,461,813
Operating Profit604,5881,135,8076,082,4142,464,610292,109-635,311394,299126,498395,3481,288,6411,838,952403,17019,177447,638-436,280
Interest Payable
Interest Receivable
Pre-Tax Profit771,0001,220,0004,915,0001,950,000238,000-617,000331,000107,000327,0001,028,0001,425,000313,00020,000328,000-433,000
Tax
Profit After Tax771,0001,220,0004,915,0001,950,000238,000-617,000331,000107,000327,0001,028,0001,425,000313,00020,000328,000-433,000
Dividends Paid
Retained Profit771,0001,220,0004,915,0001,950,000238,000-617,000331,000107,000327,0001,028,0001,425,000313,00020,000328,000-433,000
Employee Costs9,430,0007,954,0007,153,0007,079,0007,220,0007,050,0006,799,0006,356,0006,157,0005,921,0005,681,0005,249,0004,902,0004,613,0004,636,000
Number Of Employees266242273284297290286264269266249224210199177
EBITDA*1,111,5881,629,8076,561,4142,931,610759,109-140,311870,299608,498395,3481,741,6412,308,952860,170450,177831,638-114,280

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets7,957,0007,707,0007,883,0008,078,0008,417,0008,141,0008,311,0008,437,0008,614,0008,702,0008,005,0006,984,0007,180,0007,230,0007,272,000
Intangible Assets
Investments & Other5,553,0001,986,000108,000154,00077,00099,000101,00096,000
Debtors (Due After 1 year)
Total Fixed Assets13,510,0009,693,0007,883,0008,078,0008,417,0008,141,0008,311,0008,437,0008,614,0008,810,0008,159,0007,061,0007,279,0007,331,0007,368,000
Stock & work in progress18,00015,00013,00021,00016,00013,00012,0005,0007,0004,0004,0003,0009,0002,0003,000
Trade Debtors62,000413,000163,000275,000314,00027,000158,000108,000175,000109,000101,000123,00052,00040,000127,000
Group Debtors
Misc Debtors1,549,0001,002,0004,076,0002,243,0001,980,0001,535,0001,291,0001,058,0001,025,000711,000731,000336,000291,000264,000354,000
Cash6,532,0009,598,0007,831,0006,299,0001,295,0002,142,0002,741,0002,996,0002,806,0002,555,0002,495,0002,184,0001,285,0001,855,0001,312,000
misc current assets533,000507,000509,000504,000500,000500,000
total current assets8,694,00011,535,00012,083,0008,838,0004,114,0004,221,0004,702,0004,167,0004,013,0003,379,0003,331,0002,646,0002,137,0002,161,0001,796,000
total assets22,204,00021,228,00019,966,00016,916,00012,531,00012,362,00013,013,00012,604,00012,627,00012,189,00011,490,0009,707,0009,416,0009,492,0009,164,000
Bank overdraft
Bank loan
Trade Creditors 379,000265,000271,000224,000165,000175,000245,000217,000205,000154,000348,000128,000115,000272,000134,000
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities682,000886,000824,000736,000361,000420,000384,000334,000476,000416,000570,000512,000567,000504,000647,000
total current liabilities1,061,0001,151,0001,095,000960,000526,000595,000629,000551,000681,000570,000918,000640,000682,000776,000781,000
loans2,000,000
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities2,000,000
total liabilities1,061,0001,151,0001,095,0002,960,000526,000595,000629,000551,000681,000570,000918,000640,000682,000776,000781,000
net assets21,143,00020,077,00018,871,00013,956,00012,005,00011,767,00012,384,00012,053,00011,946,00011,619,00010,572,0009,067,0008,734,0008,716,0008,383,000
total shareholders funds21,143,00020,077,00018,871,00013,956,00012,005,00011,767,00012,384,00012,053,00011,946,00011,619,00010,572,0009,067,0008,734,0008,716,0008,383,000
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit604,5881,135,8076,082,4142,464,610292,109-635,311394,299126,498395,3481,288,6411,838,952403,17019,177447,638-436,280
Depreciation507,000494,000479,000467,000467,000495,000476,000482,000453,000470,000457,000431,000384,000322,000
Amortisation
Tax
Stock3,0002,000-8,0005,0003,0001,0007,000-2,0003,0001,000-6,0007,000-1,0003,000
Debtors196,000-2,824,0001,721,000224,000732,000113,000283,000-34,000380,000-12,000373,000116,00039,000-177,000481,000
Creditors114,000-6,00047,00059,000-10,000-70,00028,00012,00051,000-194,000220,00013,000-157,000138,000134,000
Accruals and Deferred Income-204,00062,00088,000375,000-59,00036,00050,000-142,00060,000-154,00058,000-55,00063,000-143,000647,000
Deferred Taxes & Provisions
Cash flow from operations822,5884,507,8074,983,4143,136,610-44,891-288,311658,299514,498123,3481,405,6412,212,952708,170310,1771,004,638182,720
Investing Activities
capital expenditure-325,000-350,000-305,000-1,158,000-1,495,000-276,000-437,000-350,000-723,000
Change in Investments3,567,0001,986,000-108,000-46,00077,000-22,000-2,0005,00096,000
cash flow from investments-3,567,000-1,986,000-325,000-350,000-305,000108,000-1,112,000-1,572,000-254,000-435,000-355,000-819,000
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans-2,000,0002,000,000
Hire Purchase and Lease Commitments
other long term liabilities
share issue295,000-14,0001,00019,00080,00020,000-2,0005,0008,816,000
interest
cash flow from financing295,000-14,000-2,000,0002,001,00019,00080,00020,000-2,0005,0008,816,000
cash and cash equivalents
cash-3,066,0001,767,0001,532,0005,004,000-847,000-599,000-255,000190,000251,00060,000311,000899,000-570,000543,0001,312,000
overdraft
change in cash-3,066,0001,767,0001,532,0005,004,000-847,000-599,000-255,000190,000251,00060,000311,000899,000-570,000543,0001,312,000

keech hospice Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for keech hospice. Get real-time insights into keech hospice's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Keech Hospice Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for keech hospice by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in LU3 area or any other competitors across 12 key performance metrics.

keech hospice Ownership

KEECH HOSPICE group structure

Keech Hospice has 1 subsidiary company.

Ultimate parent company

KEECH HOSPICE

02904446

1 subsidiary

KEECH HOSPICE Shareholders

--

keech hospice directors

Keech Hospice currently has 12 directors. The longest serving directors include Mr Peter Cannon (Jun 2018) and Mrs Miriam Heyes (Jan 2019).

officercountryagestartendrole
Mr Peter CannonEngland66 years Jun 2018- Director
Mrs Miriam HeyesEngland44 years Jan 2019- Director
Mr Jeffrey LustigEngland71 years Mar 2020- Director
Mr Michael McMahonEngland70 years Mar 2020- Director
Mr Simon OgdenEngland63 years Mar 2021- Director
Mr Chandra ShekarEngland55 years Mar 2021- Director
Ms Debra SmithEngland65 years Oct 2023- Director
Mrs Judith Greevy69 years Oct 2023- Director
Mr Iain MalcolmEngland62 years Nov 2023- Director
Ms Rowena CraddockEngland44 years Mar 2025- Director

P&L

March 2024

turnover

15.4m

+15%

operating profit

604.6k

0%

gross margin

38.5%

+1.94%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

21.1m

+0.05%

total assets

22.2m

+0.05%

cash

6.5m

-0.32%

net assets

Total assets minus all liabilities

keech hospice company details

company number

02904446

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

86900 - Other human health activities

incorporation date

March 1994

age

31

incorporated

UK

ultimate parent company

None

accounts

Group

last accounts submitted

March 2024

previous names

keech hospice care (March 2025)

pasque charity (September 2009)

See more

accountant

-

auditor

HAYSMACINTYRE LLP

address

keech hospice care, great bramingham lane, luton, LU3 3NT

Bank

NATIONAL WESTMINSTER BANK PLC

Legal Advisor

PICTONS LLP PINNEY TALFOURD LLP SA LAW VEALE WASBOROUGH VIZARDS LLP

keech hospice Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to keech hospice. Currently there are 1 open charges and 0 have been satisfied in the past.

keech hospice Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for KEECH HOSPICE. This can take several minutes, an email will notify you when this has completed.

keech hospice Companies House Filings - See Documents

datedescriptionview/download